D. Boral ARC Acquisition I Corp.

Acquiring shareholders must decide whether to hold, vote, or exercise redemption rights before the February 1, 2027 cutoff, directly impacting their exposure to a transaction that the BCAR Board calculates would yield an implied post-combination value of $4.80 per share—a 53.69% decrease from the $10.36 trust baseline. This structural dilution creates explicitly acknowledged conflicts of interest, as the BCAR Board warns sponsors may be incentivized to close rather than liquidate despite potential value erosion for public investors. Exascale’s audited financials reveal recurring net losses, an accumulated deficit of $21,134,012 as of March 31, 2026, and a going concern qualification, while Exascale management projects rapid top-line expansion reaching $20.0 million for 2026, $40.0 million for 2027, and $80.0 million for 2028. Exascale’s strategic positioning relies on an asset-light, software-defined GPU compute platform and GaaS model targeting a market a September 2025 Gartner report projected would reach nearly $1.5 trillion in 2025 and exceed $2.0 trillion in 2026, though Exascale notes its complementary infrastructure solutions have yet to generate commercial revenue and the company historically served 55 distinct customers with single-client revenue concentrations exceeding 14.0%. No pending or threatened litigation is reported, and key executive transitions place Hoansoo Lee and Wenying Jia in dual CEO/Chair roles under the new PubCo governance structure, with five appointed directors including independent academicians and industry investors.

The 20-vote Class B structure hands the target absolute voting control (91%-95%) on day one regardless of redemptions, so public holders are buying a non-controlling economic stub in an AI-infrastructure company whose hardware lines have zero revenue. A fixed 50 million share price means redemptions transfer ownership to sellers rather than reducing what they receive.

The filing contains the definitive terms of the de-SPAC transaction, including the $500 million enterprise value, the 50 million share merger consideration, the dual-class voting structure (Class A 1 vote, Class B 20 votes), the minimum cash condition of $5 million, and the redemption mechanics. It provides the target company's financials (Exascale had $7.0M revenue in FY2025, net loss of $7.7M) and key risk factors including going concern qualification. The filing also sets the redemption deadline (two business days before the meeting) and indicates the trust account value per share (approximately $10.26 as of March 31, 2026). The deadline for business combination is February 1, 2027 (extendable to May 1, 2027).

As outlined in the Risk Factors and proxy materials, these disclosures are critical because the merger remains contingent on securing alternative financing, obtaining shareholder approval, and navigating sponsor economic conflicts (e.g., Founder Shares acquired for $25,000 converting to approximately 12.2 million PubCo shares post-deal). The updated financials and going concern warning directly impact the valuation trajectory relative to the February 1, 2027 liquidation deadline, while the dual-class structure and private share purchase mechanisms materially alter redemption economics and concentrate post-merger voting control with Exascale founders.

The filing discloses the precise timeline and conditions governing shareholder capital allocation: Public Shareholders must deliver certificates or utilize the DWAC system at least two business days prior to the Extraordinary General Meeting to exercise redemption rights. The BCAR Board and management confirm a mandatory $5,000,000 Minimum Cash Financing condition precedent, warn that the SPAC will liquidate on February 1, 2027 (extendable to May 1, 2027 via Sponsor election), and detail the post-combination dual-class structure where 30,744,000 PubCo Class B Super Common Stock (held by Exascale founders and affiliated trusts/entities) will carry 20 votes per share, resulting in 89.2% to 95.0% voting control depending on redemption levels. It also attributes heavy sponsor economic exposure to the deal's success, noting the $2,025,000 combined cost for Founder Shares and Private Units becomes worthless upon failure, while the trust balances outlays roughly $10.35 per share.

Beyond the mechanics, the incorporated press release details commercial developments without financial disclosures; Exascale Labs CEO Dr. Hoansoo Lee claims coupling Compal’s hardware with Exascale’s infrastructure will allow joint customers to move from purchase order to live AI capacity in months rather than years, while Compal Vice President Alan Chang attributes complementary thermal and power challenges to their respective product lines. The text specifies Compal will display AI server platforms including OG231-2-L1, OG430-2-L1, and SGX30-2 systems alongside Direct Liquid Cooling technology, paired with Exascale’s Modular Data Center and 800 V DC solid-state transformer architecture. The showcase is scheduled for Computex Taipei 2026 (June 2-5, 2026 at booth M0804). For holders weighing redemption versus remaining in the trust vehicle, this filing provides verified operational narrative and partnership validation ahead of the February 1, 2027 termination window, though no pricing, revenue, or customer contract figures are supplied.

This is the trust-value and deal-progress checkpoint for BCAR holders: the Company confirms the trust holds $287,319,687, or $10.26 per redeemable share, and states the underwriters will not be entitled to any deferred underwriting fee at closing of the business combination, so redemption proceeds are not reduced by that item. It reiterates the Exascale transaction remains the intended business combination and that the combination period is 18 months from the August 1, 2025 IPO close, with one optional three-month sponsor extension. The filing also highlights sponsor conduct and risk: sponsor MFH 1, LLC waived redemption rights, may convert up to $2,500,000 of working capital loans into private units, has not been asked to reserve for its trust indemnification, and its only assets are company securities. With operating cash of $243,576, working capital of $54,122, and substantial doubt about going concern absent a closing, this filing matters for anyone tracking BCAR's timeline, trust value, and deal execution risk.

This filing provides the first detailed public disclosure of Exascale’s business model, financial statements, risk factors, and the transaction structure. It reveals that Exascale has a going concern qualification, incurred net losses of $7.7 million in fiscal year 2025 and $5.3 million in the six months ended December 31, 2025, and had only $1.0 million in cash as of December 31, 2025. The dual-class voting structure (Class B with 20 votes per share vs. Class A with 1 vote) concentrates control with the founders, a significant governance consideration. The absence of a fairness opinion, reliance on valuation benchmarking with large-cap comparables, and the material weaknesses in internal controls are notable risk factors. The filing also warns that the Domestication Merger may be a taxable event for U.S. holders, and that BCAR may be treated as a PFIC.

Attributed to the investor presentation and Exascale management, audited revenues reached $7,016 thousand for the fiscal year ended June 30, 2025 versus $1,319 thousand for FY2024, with $6,807 thousand recorded in the six months ended December 31, 2025, expanding reported gross margins from 4.2% to 15.8%. Management attributes 22 enterprise customers across 12 countries, a 92% fiscal-year retention cohort, a 95.5% average GPU utilization rate, and an annualized average revenue per customer of $300 thousand. Strategically, management positions the company as an asset-light, software-defined deployment partner competing on engineering velocity rather than capital intensity, supplying GPU-as-a-Service alongside modular data centers, high-density liquid cooling, and Solid State Transformer HVDC power architectures. Market sizing and macro tailwinds are attributed to cited external authorities (McKinsey, Bain, IEA, Bloomberg, S&P Global, Deloitte, Reuters, and hyperscaler disclosures), projecting a $5.2 trillion AI addressable market by 2030, AI workloads consuming 70% of data center capacity, and over $690 billion allocated to the Stargate initiative alongside billions in committed 2026 infrastructure budgets from Microsoft, Alphabet, Amazon, and Meta. Management monitors a non-binding qualified commercial pipeline estimated between $300 million and $500 million for tier-one AI infrastructure and GPU service deployments spanning North America and APAC. Executive oversight features CEO/Interim CFO Hoansoo Lee, with a board that includes Chairman Wenying Jia and Lead Director David Card (2021 Nobel Laureate in Economics). Prior capital formation is detailed through sequential SAFE tranches, capped by a March 2026 $3 million round at a $500 million valuation, followed by a January 2026 definitive merger agreement that sets a negotiated $500 million pre-money valuation without any attached third-party fairness opinion.

Management attributes specific operational and financial metrics to Exascale: audited GAAP revenue figures rose from $1,319 (FY2024) to $7,016 (FY2025), with $6,807 recorded in H1 FY2026 compared to $2,614 in the prior-year period. The company reports 22 enterprise customers across 12 countries, a 92% client retention rate, and $300K in annualized average revenue per customer. Management projects a $300M–$500M qualified pipeline spanning 15 active opportunities across North America and APAC, representing approximately 500 MW of prospective deployment capacity. Strategically, Exascale emphasizes an asset-light, software-defined model utilizing modular data centers, HVDC/solid-state transformer power architectures, and high-density liquid cooling. Prior financing milestones cited include a November 2025 $500K bridge SAFE at a $300M cap, a December 2024 $7.501M SAFE at a $150M cap, and a March 2026 $3M SAFE at a $500M cap. The designated Board features CEO Hoansoo Lee, Chairperson Wenying Jia, Lead Director Prof. David Card, and Compensation Committee Chair Prof. Shachar Kariv. For macroeconomic context, Exascale attributes industry forecasts from McKinsey, Bain & Company, Introl, S&P Global, Deloitte, Reuters, Turner & Townsend, and IEA, citing a projected $5.2T global AI-ready data center capital expenditure market by 2030 and listing 2026 hyperscaler spending estimates sourced directly from Microsoft, Alphabet, Amazon, Meta, OpenAI, and SoftBank.

Per the filing, the unresolved financing condition introduces immediate execution risk that could derail the timeline before the February 1, 2027 (or May 1, 2027) deadline, directly impacting trust distribution mechanics and shareholder exit options.

Confirms trust value, deadline timeline (18 months from Aug 2025 with optional 3-month extension), and the execution of a $500M business combination agreement. Provides audited financials and details on sponsor arrangements and redemption mechanics.

These disclosures directly frame the shareholder vote and redemption calculus. According to the BCAR Board’s stated rationale, the board approved the combination because it believes Exascale possesses 'strong revenue growth potential,' though the board acknowledged obtaining no independent fairness opinion. Warning letters highlight sponsor conflicts of interest, noting the Sponsor may earn positive returns even if public shareholders suffer negative ones, particularly if funds are released before February 1, 2027.

The filing establishes public record of an institutional investor’s equity position, which creates baseline voting leverage that may influence shareholder approvals or redemption behavior. Because the excerpt omits the exact share count, acquisition dates, and investment purpose statement normally required in a 13G, the precise scale of Meteora Capital’s holding and its intent regarding the deal timeline or trust distributions cannot be assessed from this text.

This definitive agreement sets the terms for the SPAC merger. Trust value is $10.35 per share, but the merger consideration values shares at $10.00, implying a potential discount for redeeming shareholders. The very low $5 million minimum cash condition means the deal could close with minimal trust proceeds after redemptions, increasing risk for public shareholders. The sponsor's commitment not to redeem and the majority shareholder support reduce uncertainty. The target (Exascale) claims a $300 million+ contract pipeline and operates in the high-demand AI infrastructure sector, but no audited financials are provided yet. The lock-up period for the majority shareholder is only 6 months. Investors should monitor the S-4, redemption levels, and the ability to meet the minimum cash condition.

This is the definitive deal announcement, establishing all key terms: trust per share is $10.35 (from pre-existing data, not this filing), the $500M enterprise value, the $5M minimum cash condition, the outside date of September 1, 2026, and the requirement for audited PCAOB financials by Jan 31. The sponsor has agreed to vote for the deal and waive anti-dilution rights. The target (Exascale) claims a $300M+ contract pipeline, blue-chip customers including MIT and NVIDIA-acquired Lepton.ai, and a $50M+ MOU. The post-close board will have 5 directors, all Exascale-designated. Exascale's majority shareholder will sign a 6-month lock-up.

The trust value per share of $10.07 is slightly above the $10.00 IPO price due to interest, which is normal. The company has ample time to pursue a combination. The filing confirms the sponsor's founder shares are subject to forfeiture and the company has minimal liabilities. For redemption calendar tracking, note that redemptions could occur upon a future shareholder vote or tender offer. No extension or vote is currently scheduled.

This filing establishes the baseline trust value ($280 million, $10.00 per share), the redemption rights, and the deadline for a business combination (18 months plus potential extension). It also details sponsor economics (low-cost founder shares, private placement, and service fees) and the underwriter compensation, which are important for assessing sponsor alignment and future dilution. No target has been identified, but the filing confirms the sponsor's commitment to waive redemption rights and vote for a deal.

This filing does not amend the February 1, 2027 redemption deadline, alter the $10.35 per-share trust balance noted in prior disclosures, or provide updates on deal progress or sponsor conduct. Its impact is purely mechanical and operational: it changes Nasdaq trading conditions by decoupling equity from derivative instruments, which immediately affects liquidity, hedge structuring, and position accounting for public shareholders. Investors holding Units must instruct their brokers before market open on August 20, 2025 if they intend to trade the shares or warrants independently. The strategic sector focus and forward-looking language are verbatim restatements from the IPO prospectus and carry no new commercial commitments.

As stated in the pro forma exhibit, this transaction finalizes the capital accumulation phase, locking the definitive trust balance ($280,000,000) and public share count (28,000,000) that will determine per-share payout math during any future redemption or liquidity event. By isolating the remaining non-trust liabilities ($400,325) and founder share positions, the Company establishes the baseline balance sheet required before initiating target acquisition activities. The filing discloses no information regarding potential targets, revenue projections, market positioning, technological pipelines, partnership agreements, litigation matters, or executive compensation, focusing exclusively on post-offering structural accounting.

The $250,000,000 trust baseline defines the maximum redemption pool, though the Company specifies that final per-share redemption amounts will equal the aggregate trust balance divided by outstanding public shares, potentially falling below the initial $10.00 floor due to taxes, dissolution expenses capped at $100,000 of interest, or asset value reductions. The 18-month primary deadline plus one three-month extension sets the absolute window for deal completion or mandatory liquidation. The Sponsor’s indemnification pledge shields the trust from certain third-party claims, but the Company explicitly discloses it cannot assure the Sponsor can satisfy this obligation because its “only assets are securities of our company,” introducing direct credit risk to public shareholders. The 1,607,143 forfeitable founder shares align sponsor equity retention with full over-allotment execution. The $20,000 monthly administrative draw and potential $2,500,000 working capital facility establish predefined cash outflow mechanisms during the pre-combination search period. The documented warrant metrics—including a $11.50 exercise price, 30-day post-combination exercisability, five-year expiration, $18.00 call redemption trigger over a 20-trading-day/30-trading-day measurement period, and anti-dilution resets tied to $9.20 Newly Issued Prices and 60% gross proceeds thresholds—lock in future equity structuring and dilution parameters. The Company’s admission that it has generated no operating revenues and relies entirely on trust interest income and external financing to fund operations until a business combination confirms the entity is purely a shell vehicle awaiting target execution, with the auditor’s going concern conclusion contingent on successfully navigating the defined Combination Period.

As recorded in the filing and context, the $10 open-market purchase price trades below the $10.35 per-share trust valuation noted in the header. According to the Form 4, this indicates that principals and executive leadership are absorbing public shares outside of the trust mechanism, which contracts available float and demonstrates that insiders view the secondary market price as dislocated from the archived cash backing. The submission does not disclose modifications to the February 1, 2027 redemption calendar, trigger no extension protocols, and leave the approved deal pathway intact, though the concentrated buying activity by named officers may serve as a market signal ahead of merger integration milestones.

The SPAC is now a public shell with a trust of $10.00 per share (initial), an 18-month deadline expiring around February 1, 2027 (with a possible 3-month extension), and standard founder/insider lock-ups. No business combination target has been identified. Investors tracking redemption rights and deal progress now have a clean IPO closing to reference.

The document initializes the economic and governance parameters governing future redemption deadlines, trust distribution mechanics, and extension voting. Management represents a strategic focus on acquiring businesses with an aggregate enterprise value of $700 million or greater, while cautioning that historical performance by officers across prior SPACs (EF Hutton Acquisition Corporation I, Northern Lights Acquisition Corp., Edoc Acquisition Corp., and InFinT Acquisition Corporation) is not indicative of future results.

What changed: A Form 425 communication filed by D. Boral ARC Acquisition I Corp. pursuant to Rule 425 of the Securities Act and Rule 14a-12 of the Exchange Act, containing a press release issued by target company Exascale Labs Inc. This filing does not amend the merger agreement, modify shareholder redemption rights, adjust the trust value ($10.35 per share), or alter the February 1, 2027 liquidation deadline. It instead disseminates a July 21, 2026 press release attributed to Exascale Labs Inc. and quoting Hoansoo Lee, Chief Executive Officer of Exascale, who claimed the company is advancing an 'estimated $300 million customer opportunity pipeline' through recent commercial developments. The filing reports three specific arrangements: (1) a non-binding MOU with RUTILEA for the potential development and commercialization of up to 20MW of data center capacity, noting that while parties expect to negotiate a definitive agreement, 'no assurance can be given'; (2) a recently announced $71.4 million three-year compute services agreement with Dimension AI securing dedicated GPU compute capacity; and (3) a $53 million AI Nova non-binding MOU contemplating initial orders for GPU servers and related technical services, also subject to definitive agreement negotiations without assurance of execution. Additionally, the filing notes Exascale partnered with global IT leader Compal Electronics to showcase modular data center, HVDC, and solid-state transformer offerings at COMPUTEX Taipei 2026. Management characterizes Exascale as operating an asset-light, software-defined GPU compute platform purpose-built for LLM training, fine-tuning, and high-concurrency inference. All pipeline metrics and revenue projections are presented as forward-looking expectations contingent on market demand, GPU supply chains, and binding contract execution. Why it matters: This Rule 425 submission functions exclusively as a commercial progress update and investor relations communication, leaving the SPAC redemption calendar, trust account composition, and extension provisions untouched. For holders tracking deal mechanics, it confirms the transaction remains on track toward the approved business combination while providing zero contractual leverage over redemption timing or trust distributions. From a target viability perspective, the filing highlights management’s strategy to monetize both GPU-as-a-Service and physical infrastructure solutions, but the explicit non-binding status of the $53 million and $300 million pipeline figures significantly tempers near-term cash flow predictability. Only the $71.4 million Dimension AI commitment constitutes a firm financial obligation. The extensive forward-looking disclaimers and conditionality language reinforce that actual revenue recognition depends on successfully negotiating definitive agreements, overcoming hardware procurement bottlenecks, and satisfying merger closing conditions. Investors should weigh these announcements as strategic positioning indicators with no direct mathematical or procedural impact on their redemption calculations or sponsor governance oversight.

What changed: A press release announcing a commercial customer contract, filed as an SEC Form 425 submission because it constitutes prospectus-related communication tied to the pending business combination between D. Boral ARC Acquisition I Corp. and Exascale Labs Inc. Nothing altered regarding the redemption calendar, trust per share balance, extension authorization, or sponsor behavior. The deal remains post-shareholder approval, with the definitive Proxy Statement and registration statement already distributed to BCAR investors as the parties move toward final closing. Why it matters: This filing delivers commercial substantiation rather than mechanical adjustments. Per the filing, Exascale entered a three-year Compute Service Agreement to procure approximately US$71.4 million of dedicated GPU compute capacity from Dimension AI Pte. Ltd., a Singapore-based enterprise technology distributor. Hoansoo Lee, CEO of Exascale, stated that securing long-term access to high-performance GPU capacity represents an important milestone for scaling the AI infrastructure platform and improving service reliability for growing customer needs. Lionel Peh, Director of Dimension AI, remarked that the partnership demonstrates strong demand for dedicated, high-performance compute capacity. The agreement funds expansion of Exascale’s GPU-as-a-Service and token factory platform, which operates an asset-light, software-defined model sourcing reserved and on-demand capacity from global third-party data centers. The filing further details Exascale’s proprietary work on modular data center, high-density cooling, HVDC power, and energy storage solutions designed to resolve AI infrastructure deployment bottlenecks, with the platform optimized for LLM training, fine-tuning, and high-concurrency inference. These confirmed procurement commitments and hardware/software developments validate the merger’s revenue and scalability assumptions while leaving shareholder exit rights and trust distribution procedures entirely unaffected.

What changed: A Form 8-K current report containing Item 8.01 disclosures and Exhibit 99.1, a joint press release that formally schedules an Extraordinary General Meeting of D. Boral ARC Acquisition I Corp. (BCAR) shareholders to vote on a previously executed Agreement and Plan of Merger with Exascale Labs Inc. The filing sets an Extraordinary General Meeting for Wednesday, July 29, 2026 at 10:00 AM Eastern Time, establishing Monday, July 6, 2026 as the record date for shareholder attendance and voting eligibility. The definitive Proxy Statement has been mailed to BCAR shareholders of record. The companies state the Business Combination is expected to close shortly following the shareholder meeting, contingent upon shareholder approval and the satisfaction or waiver of specified closing conditions. While this 8-K does not restate redemption mechanics or trust account balances, it directs investors to the filed Registration Statement on Form S-4 (File No. 333-297214) for complete details on voting procedures, redemption rights, and trust distributions. The filing also confirms registered Class A ordinary shares carry a par value of $0.0001 per share and that whole warrants are exercisable at an exercise price of $11.50 per share. Why it matters: Shareholders face a fixed decision window requiring proxy authorization or redemption execution prior to the July 6, 2026 record date, after which corporate action accelerates toward the anticipated post-meeting closing. According to the joint press release, upon closing the combined enterprise will operate as Exascale Labs Holdings Inc. and list on Nasdaq under ticker “XLAB.” The press release describes Exascale as a next-generation AI infrastructure provider offering GPU-as-a-Service through reserved and on-demand access to high-performance GPU compute capacity sourced from third-party global data centers, supplemented by GPU cluster management and optimization services. The company states it has developed modular data center, high-density cooling, HVDC power, and energy storage solutions intended to resolve AI infrastructure deployment bottlenecks, with a platform engineered for large-scale AI workloads including LLM training, fine-tuning, and high-concurrency inference. Forward-looking statements attributable to BCAR, Exascale, and PubCo caution that actual outcomes may differ materially due to supply constraints for GPUs and related components, shifts in customer demand, competitive pressures, technological risks, operational performance variables, regulatory changes, and macroeconomic factors.

What changed: A Form 8-K filing pursuant to Rule 425 containing a joint press release that schedules an Extraordinary General Meeting of D. Boral ARC Acquisition I Corp. (BCAR) shareholders to approve a previously announced business combination agreement dated January 11, 2026. The filing establishes the shareholder meeting date for Wednesday, July 29, 2026 at 10:00 AM Eastern Time, with a record date of Monday, July 6, 2026. It confirms the definitive Proxy Statement has been mailed to BCAR shareholders and states the business combination is expected to close shortly following shareholder approval, subject to the satisfaction or waiver of certain closing conditions. Why it matters: This filing fixes the proximate deadline for BCAR investors to examine proxy disclosures, exercise redemption rights, and cast votes ahead of the July 29 meeting. Attached is a July 7, 2026 press release attributing to Exascale Labs Inc. a business model defined as an 'asset-light, software-defined GPU compute platform' delivering reserved and on-demand GPU access via third-party global data centers, alongside GPU cluster management and optimization services. The same release attributes to Exascale the creation of modular data centers, high-density cooling, HVDC power, and energy storage solutions designed to resolve AI infrastructure deployment bottlenecks for LLM training, fine-tuning, and high-concurrency inference workloads. BCAR and Exascale jointly announce the combined company will operate as Exascale Labs Holdings Inc. and list on Nasdaq under the ticker 'XLAB'. All operational descriptions, technology roadmaps, and market positioning claims are sourced exclusively to the joint Exascale and BCAR press release. The filing also lists a whole warrant exercise price of $11.50 per share for BCARW.

What changed: Definitive 424(b)(3) proxy statement/prospectus (Reg. No. 333-297214) for D. Boral ARC Acquisition I Corp.'s combination with Exascale Labs Inc. under an Agreement and Plan of Merger dated January 11, 2026, registering up to 60,456,000 Class A shares, 30,744,000 Class B super-voting shares and 14,100,000 warrants. BCAR redomiciles from the BVI to Delaware by merging into D. Boral ARC Merger Corporation, which is renamed Exascale Labs Holdings Inc., then Merger Sub merges into Exascale, an asset-light GPU-as-a-Service and AI-infrastructure provider whose modular data center, liquid cooling, HVDC and energy-storage products have generated no revenue to date. Merger consideration is a fixed 50,000,000 PubCo shares (19,256,000 Class A and 30,744,000 Class B). Class B carries 20 votes per share, so former Exascale holders control 91.1% of the vote with no redemptions, 93.0% at 50% redemption and 95.0% at maximum redemption, while non-affiliated public holders fall from 28,000,000 shares (30.7% economic, 4.2% voting) to zero at maximum redemption. Insiders receive 13,200,000 shares (12,000,000 sponsor Class B, 200,000 private-unit shares, 1,000,000 representative shares held by BCAR's Chairman/CEO). Nasdaq listing under XLAB/XLABW is applied for and is a closing condition; 100,000 private and 14,000,000 public warrants are excluded from the tables. Why it matters: The 20-vote Class B structure hands the target absolute voting control (91%-95%) on day one regardless of redemptions, so public holders are buying a non-controlling economic stub in an AI-infrastructure company whose hardware lines have zero revenue. A fixed 50 million share price means redemptions transfer ownership to sellers rather than reducing what they receive.

What changed: Definitive Proxy Statement/Prospectus (DEFM14A) for an Extraordinary General Meeting scheduled for July 29, 2026, designed to solicit shareholder votes on the proposed business combination, corporate domestication, and associated governance amendments between D. Boral ARC Acquisition I Corp. (BCAR) and Exascale Labs Inc. The filing establishes a definitive voting timeline ahead of the February 1, 2027 business combination deadline (extendable to May 1, 2027 if the Sponsor exercises its three-month extension option). Per the BCAR Board, the trust account held approximately $290,025,825.19 as of July 6, 2026, implying a per-share redemption price of approximately $10.36. The BCAR Board states that Exascale securityholders will collectively receive 50,000,000 PubCo Common Stock valued at $10.00 per share for a $500,000,000 consideration. The filing confirms that no Minimum Cash Financing of at least $5,000,000 has been secured as of the document date. Regarding sponsor conduct, the BCAR Board discloses that MFH 1, LLC invested an aggregate of $2,025,000 across 12,000,000 Founder Shares and 200,000 Private Units, and outlines ongoing monthly administrative service obligations of $20,000 alongside potential working capital loans up to $2,500,000. Deal progress reflects unanimous board approvals for all eight proposals, with sponsorship support agreements locked in, lock-up commitments executed for Exascale holders, and proxy solicitation costs fixed at $12,500 plus disbursements via Advantage Proxy. Why it matters: Acquiring shareholders must decide whether to hold, vote, or exercise redemption rights before the February 1, 2027 cutoff, directly impacting their exposure to a transaction that the BCAR Board calculates would yield an implied post-combination value of $4.80 per share—a 53.69% decrease from the $10.36 trust baseline. This structural dilution creates explicitly acknowledged conflicts of interest, as the BCAR Board warns sponsors may be incentivized to close rather than liquidate despite potential value erosion for public investors. Exascale’s audited financials reveal recurring net losses, an accumulated deficit of $21,134,012 as of March 31, 2026, and a going concern qualification, while Exascale management projects rapid top-line expansion reaching $20.0 million for 2026, $40.0 million for 2027, and $80.0 million for 2028. Exascale’s strategic positioning relies on an asset-light, software-defined GPU compute platform and GaaS model targeting a market a September 2025 Gartner report projected would reach nearly $1.5 trillion in 2025 and exceed $2.0 trillion in 2026, though Exascale notes its complementary infrastructure solutions have yet to generate commercial revenue and the company historically served 55 distinct customers with single-client revenue concentrations exceeding 14.0%. No pending or threatened litigation is reported, and key executive transitions place Hoansoo Lee and Wenying Jia in dual CEO/Chair roles under the new PubCo governance structure, with five appointed directors including independent academicians and industry investors.

What changed: S-4 registration statement (proxy statement/prospectus) filed by D. Boral ARC Acquisition I Corp. (BCAR) to register securities and solicit shareholder approval for the proposed business combination with Exascale Labs Inc., including a domestication merger and acquisition merger. This is the initial filing of the S-4, which sets forth the terms of the business combination agreement, the merger consideration, pro forma ownership, redemption rights, financial statements of both BCAR and Exascale, risk factors, and the proxy solicitation for the extraordinary general meeting scheduled for 2026. No prior S-4 had been filed; this is the first comprehensive disclosure of the transaction. Why it matters: The filing contains the definitive terms of the de-SPAC transaction, including the $500 million enterprise value, the 50 million share merger consideration, the dual-class voting structure (Class A 1 vote, Class B 20 votes), the minimum cash condition of $5 million, and the redemption mechanics. It provides the target company's financials (Exascale had $7.0M revenue in FY2025, net loss of $7.7M) and key risk factors including going concern qualification. The filing also sets the redemption deadline (two business days before the meeting) and indicates the trust account value per share (approximately $10.26 as of March 31, 2026). The deadline for business combination is February 1, 2027 (extendable to May 1, 2027).

What changed: S-4/A (Amendment No. 1 to Registration Statement on Form S-4) containing a Proxy Statement and Prospectus for a proposed business combination. Per the Proxy Statement, this amendment incorporates unaudited financial statements through March 31, 2026; revises organizational document proposals to codify dual-class voting rights granting twenty votes per PubCo Class B Super Common Stock share; discloses that Exascale’s management acknowledges substantial doubt regarding its ability to continue as a going concern due to recurring net losses and negative cash flows; confirms neither BCAR nor Exascale has secured the $5,000,000 Minimum Cash Financing condition precedent as of the filing date; and clarifies governance rules permitting the Sponsor to privately acquire up to 15% of Public Shares to reduce redemptions. Why it matters: As outlined in the Risk Factors and proxy materials, these disclosures are critical because the merger remains contingent on securing alternative financing, obtaining shareholder approval, and navigating sponsor economic conflicts (e.g., Founder Shares acquired for $25,000 converting to approximately 12.2 million PubCo shares post-deal). The updated financials and going concern warning directly impact the valuation trajectory relative to the February 1, 2027 liquidation deadline, while the dual-class structure and private share purchase mechanisms materially alter redemption economics and concentrate post-merger voting control with Exascale founders.